Detalhe da pesquisa
1.
Longitudinal Retinal Perfusion Status in Eyes with Diabetic Macular Edema Receiving Intravitreal Aflibercept or Laser in VISTA Study.
Ophthalmology
; 126(8): 1171-1180, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30946887
2.
Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia.
Cardiovasc Drugs Ther
; 33(1): 69-76, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30734207
3.
Baseline Factors Affecting Changes in Diabetic Retinopathy Severity Scale Score After Intravitreal Aflibercept or Laser for Diabetic Macular Edema: Post Hoc Analyses from VISTA and VIVID.
Ophthalmology
; 125(1): 51-56, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28764888
4.
Correction to: Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials.
Cardiovasc Drugs Ther
; 32(2): 181, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29713852
5.
Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials.
Cardiovasc Drugs Ther
; 32(2): 175-180, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29627892
6.
Differential Response to Anti-VEGF Regimens in Age-Related Macular Degeneration Patients with Early Persistent Retinal Fluid.
Ophthalmology
; 123(9): 1856-64, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27369111
7.
Comprehensive Review of Ocular and Systemic Safety Events with Intravitreal Aflibercept Injection in Randomized Controlled Trials.
Ophthalmology
; 123(7): 1511-20, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27084563
8.
Intraocular Pressure in Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Aflibercept or Ranibizumab.
Ophthalmology
; 122(9): 1802-10, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26025097
9.
Geographic atrophy in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
Retina
; 35(2): 176-86, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25387047
10.
Intraocular pressure in patients with neovascular age-related macular degeneration switched to aflibercept injection after previous anti-vascular endothelial growth factor treatments.
Retina
; 34(11): 2161-6, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25072648
11.
Impact of Systemic Dipeptidyl Peptidase-4 Inhibitor Use in Diabetic Macular Edema.
Ophthalmic Surg Lasers Imaging Retina
; 51(4): 226-234, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32348539
12.
Changes in neovascular activity following fixed dosing with an anti-vascular endothelial growth factor agent over 52 weeks in the phase III VIEW 1 and VIEW 2 studies.
Br J Ophthalmol
; 104(9): 1223-1227, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826853
13.
Outcomes in Patients with Diabetic Macular Edema Requiring Cataract Surgery in VISTA and VIVID Studies.
Ophthalmol Retina
; 4(5): 481-485, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31924543
14.
Alirocumab efficacy and safety by race and ethnicity: Analysis from 3 ODYSSEY phase 3 trials.
J Clin Lipidol
; 13(4): 586-593.e5, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31331789
15.
Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients With Age-Related Macular Degeneration Treated With Intravitreal Aflibercept or Ranibizumab.
JAMA Ophthalmol
; 137(8): 914-920, 2019 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31294771
16.
Difference in Treatment Effect Between Intravitreal Aflibercept Injection and Laser by Baseline Factors in Diabetic Macular Edema.
Ophthalmic Surg Lasers Imaging Retina
; 50(3): 167-173, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30893450
17.
Efficacy and Safety of Alirocumab 300 mg Every 4 Weeks in Individuals With Type 2 Diabetes on Maximally Tolerated Statin.
J Clin Endocrinol Metab
; 104(11): 5253-5262, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31166599
18.
Efficacy and safety of alirocumab in individuals with type 2 diabetes mellitus with or without mixed dyslipidaemia: Analysis of the ODYSSEY LONG TERM trial.
Atherosclerosis
; 276: 124-130, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30059843
19.
Efficacy and safety of alirocumab in patients with or without prior coronary revascularization: Pooled analysis of eight ODYSSEY phase 3 trials.
Atherosclerosis
; 277: 211-218, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30025648
20.
Impact of Baseline Characteristics on Treatment Response to Intravitreal Aflibercept Injection for Wet Age-Related Macular Degeneration.
Ophthalmol Retina
; 2(7): 676-683, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31047376